RSS-Feed abonnieren
DOI: 10.1055/a-2506-1763
Effect of Enhanced Recovery after Surgery in Morbidly Obese Patients Undergoing Free Flap Breast Reconstruction
Funding None.Abstract
Background Enhanced recovery after surgery (ERAS) pathways have been widely implemented across many surgical practices, including autologous breast reconstruction. However, the benefits of ERAS in the morbidly obese population have yet to be defined.
Methods A retrospective chart review of patients undergoing deep inferior epigastric artery perforator (DIEP) flap breast reconstruction at our institution from 2017 to 2022 was performed. Length of stay (LOS), intensive care unit (ICU) utilization, opioid usage, cost, and flap outcomes were analyzed in patients with body mass index greater than 35 before and after ERAS implementation.
Results Thirty-five morbidly obese patients receiving DIEP flap breast reconstruction were identified before ERAS and 18 after ERAS. There were no differences in unilateral versus bilateral or immediate versus delayed reconstruction. LOS decreased with ERAS (3.43 vs. 2.06 days, p < 0.0000001). ICU utilization decreased with ERAS (0.94 vs. 0.0 days, p < 0.0001). Daily and total opioid usage decreased with ERAS (41.8 vs. 17.9 morphine milligram equivalent [MME], p < 0.0001; 190.5 vs. 54.7 MME, p < 0.0001). Financial metrics improved with ERAS, including decreased total cost ($33,454 vs. $25,079, p = 0.0002) and increased cost margin ($4,458 vs. −$8,306, p = 0.004). There were no differences in donor or recipient site outcomes including flap loss, deep venous thrombosis/pulmonary embolism, hernia/bulge, delayed wound healing, revisions, and blood loss.
Conclusion ERAS pathways maintain benefits in the morbidly obese population undergoing abdominally based autologous breast reconstruction, including decreased LOS, ICU utilization, opioid use, and cost while maintaining successful reconstruction outcomes.
Presentation
This work was presented at the Virginia Society of Plastic Surgeons Annual Meeting in September 2023 as an oral presentation and will be presented at Plastic Surgery The Meeting in September 2024 as an oral presentation.
Publikationsverlauf
Eingereicht: 30. Mai 2024
Angenommen: 11. Dezember 2024
Accepted Manuscript online:
19. Dezember 2024
Artikel online veröffentlicht:
21. Januar 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69 (01) 7-34
- 2 Arnold M, Morgan E, Rumgay H. et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 2022; 66: 15-23
- 3 Nano MT, Gill PG, Kollias J, Bochner MA, Malycha P, Winefield HR. Psychological impact and cosmetic outcome of surgical breast cancer strategies. ANZ J Surg 2005; 75 (11) 940-947
- 4 Fang SY, Shu BC, Chang YJ. The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis. Breast Cancer Res Treat 2013; 137 (01) 13-21
- 5 Crompvoets S. Comfort, control, or conformity: women who choose breast reconstruction following mastectomy. Health Care Women Int 2006; 27 (01) 75-93
- 6 Neill KM, Armstrong N, Burnett CB. Choosing reconstruction after mastectomy: a qualitative analysis. Oncol Nurs Forum 1998; 25 (04) 743-750
- 7 Nissen MJ, Swenson KK, Kind EA. Quality of life after postmastectomy breast reconstruction. Oncol Nurs Forum 2002; 29 (03) 547-553
- 8 Allen RJ, Treece P. Deep inferior epigastric perforator flap for breast reconstruction. Ann Plast Surg 1994; 32 (01) 32-38
- 9 Mehta SK, Olawoyin O, Chouairi F. et al. Worse overall health status negatively impacts satisfaction with breast reconstruction. J Plast Reconstr Aesthet Surg 2020; 73 (11) 2056-2062
- 10 Lee K, Kruper L, Dieli-Conwright CM, Mortimer JE. The impact of obesity on breast cancer diagnosis and treatment. Curr Oncol Rep 2019; 21 (05) 41
- 11 Panayi AC, Agha RA, Sieber BA, Orgill DP. Impact of obesity on outcomes in breast reconstruction: a systematic review and meta-analysis. J Reconstr Microsurg 2018; 34 (05) 363-375
- 12 Gustafsson UO, Scott MJ, Hubner M. et al. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS®) society recommendations: 2018. World J Surg 2019; 43 (03) 659-695
- 13 Stenberg E, Dos Reis Falcão LF, O'Kane M. et al. Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations: a 2021 update. [published correction appears in World J Surg. 2022] World J Surg 2022; 46 (04) 729-751
- 14 Bogani G, Sarpietro G, Ferrandina G. et al. Enhanced recovery after surgery (ERAS) in gynecology oncology. Eur J Surg Oncol 2021; 47 (05) 952-959
- 15 Gort N, van Gaal BGI, Tielemans HJP, Ulrich DJO, Hummelink S. Positive effects of the enhanced recovery after surgery (ERAS) protocol in DIEP flap breast reconstruction. Breast 2021; 60: 53-57
- 16 Sharif-Askary B, Hompe E, Broadwater G, Anolik R, Hollenbeck ST. The effect of enhanced recovery after surgery pathway implementation on abdominal-based microvascular breast reconstruction. J Surg Res 2019; 242: 276-285
- 17 Anolik RA, Sharif-Askary B, Hompe E, Hopkins TJ, Broadwater G, Hollenbeck ST. Occurrence of symptomatic hypotension in patients undergoing breast free flaps: is enhanced recovery after surgery to blame?. Plast Reconstr Surg 2020; 145 (03) 606-616
- 18 Neeland IJ, Poirier P, Després JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation 2018; 137 (13) 1391-1406
- 19 Piché ME, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update. Prog Cardiovasc Dis 2018; 61 (02) 103-113
- 20 CPT® (Current Procedural Terminology) American Medical Association. Accessed: May 3, 2024 at: https://www.ama-assn.org/amaone/cpt-current-procedural-terminology
- 21 Adult obesity facts. 2022 Centers for Disease Control and Prevention. Accessed April 29, 2024 at: https://www.cdc.gov/obesity/data/adult.html
- 22 Santosa KB, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL. Long-term patient-reported outcomes in postmastectomy breast reconstruction. JAMA Surg 2018; 153 (10) 891-899
- 23 Malekpour M, Malekpour F, Wang HT. Breast reconstruction: Review of current autologous and implant-based techniques and long-term oncologic outcome. World J Clin Cases 2023; 11 (10) 2201-2212
- 24 Offodile II AC, Gu C, Boukovalas S. et al. Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature. Breast Cancer Res Treat 2019; 173 (01) 65-77
- 25 Araya S, Webster TK, Egleston B. et al. Significant reduction in length of stay in deep inferior epigastric perforator flap breast reconstruction with implementation of multimodal ERAS protocol. Ann Plast Surg 2023; 91 (01) 90-95
- 26 Shin HD, Rodriguez AM, Abraham JT. et al. “Does ERAS benefit higher BMI patients? A single institutional review”. J Plast Reconstr Aesthet Surg 2021; 74 (03) 475-479
- 27 Persing S, Manahan M, Rosson G. Enhanced recovery after surgery pathways in breast reconstruction. Clin Plast Surg 2020; 47 (02) 221-243
- 28 Haddock NT, Garza R, Boyle CE, Liu Y, Teotia SS. Defining enhanced recovery pathway with or without liposomal bupivacaine in DIEP flap breast reconstruction. Plast Reconstr Surg 2021; 148 (05) 948-957
- 29 Park RH, Chou J, DeVito RG. et al. Effectiveness of liposomal bupivacaine transversus abdominis plane block in DIEP flap breast reconstruction: a randomized controlled trial. Plast Reconstr Surg 2024; 154 (4S): 52S-59S
- 30 Batdorf NJ, Lemaine V, Lovely JK. et al. Enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg 2015; 68 (03) 395-402
- 31 Bonsignore MR. Obesity and obstructive sleep apnea. Handb Exp Pharmacol 2022; 274: 181-201
- 32 Freire C, Sennes LU, Polotsky VY. Opioids and obstructive sleep apnea. J Clin Sleep Med 2022; 18 (02) 647-652
- 33 Perry C, Guillory TS, Dilks SS. Obesity and psychiatric disorders. Nurs Clin North Am 2021; 56 (04) 553-563
- 34 Rodnoi P, Dickey RM, Teotia SS, Haddock NT. Increased opioid consumption following DIEP flap breast reconstruction: effect of depression and anxiety. J Reconstr Microsurg 2022; 38 (09) 742-748
- 35 Fischer JP, Nelson JA, Sieber B. et al. Free tissue transfer in the obese patient: an outcome and cost analysis in 1258 consecutive abdominally based reconstructions. Plast Reconstr Surg 2013; 131 (05) 681e-692e
- 36 Jandali S, Nelson JA, Sonnad SS. et al. Breast reconstruction with free tissue transfer from the abdomen in the morbidly obese. Plast Reconstr Surg 2011; 127 (06) 2206-2213
- 37 Garvey PB, Buchel EW, Pockaj BA, Gray RJ, Samson TD. The deep inferior epigastric perforator flap for breast reconstruction in overweight and obese patients. Plast Reconstr Surg 2005; 115 (02) 447-457
- 38 Lymperopoulos NS, Sofos S, Constantinides J, Koshy O, Graham K. Blood loss and transfusion rates in DIEP flap breast reconstruction. Introducing a new predictor. J Plast Reconstr Aesthet Surg 2013; 66 (12) 1659-1664
- 39 Appleton SE, Ngan A, Kent B, Morris SF. Risk factors influencing transfusion rates in DIEP flap breast reconstruction. Plast Reconstr Surg 2011; 127 (05) 1773-1782
- 40 Ting J, Rozen WM, Le Roux CM, Ashton MW, Garcia-Tutor E. Predictors of blood transfusion in deep inferior epigastric artery perforator flap breast reconstruction. J Reconstr Microsurg 2011; 27 (04) 233-238
- 41 Tuaño KR, Yang JH, Fisher MH. et al. Venous thromboembolism after deep inferior epigastric perforator flap breast reconstruction: review of outcomes after a postoperative prophylaxis protocol. Plast Reconstr Surg 2024; 154 (01) 13e-20e
- 42 DeVito RG, Craft L, Campbell CA, Stranix JT. Optimizing perioperative outcomes in autologous breast reconstruction. Gland Surg 2023; 12 (04) 508-515
- 43 Oh C, Moriarty J, Borah BJ. et al. Cost analysis of enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg 2018; 71 (06) 819-826